tirzepatide dosing information dosage chart Tirzepatide Dosage Chart & Dosing
Description
GLP-1 medications are typically appropriate for adults with a BMI of 30 or higher, or 27 or higher with weight related health conditions
After 56 weeks: Placebo group lost 1.2% of body weight Recommended dose (7.5/46 mg) group lost 7.8% of body weight Top dose (15/92 mg) group lost 9.8% of body weight The EQUIP trial enrolled 1,267 adults with class II and III obesity (BMI 35+)
Kidney function is a critical consideration because both drugs are partially eliminated through renal clearance
When medication is stopped, appetite signals may return, and weight regain can occur when no maintenance strategy is in place
